Effect of the molecular weight of water-soluble polymers on accumulation at an inflammatory site following intravenous injection

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 3, Issue 4, 1996, Pages 231-238

  Murakami, Yoshiyuki ^a   Tabata, Yasuhiko ^a   Ikada, Yoshito ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

accumulation; body distribution; inflammation; molecular weight; pharmacokinetics; water soluble polymers

Indexed keywords

CARRAGEENAN; DEXTRAN; IODINE 125; MACROGOL; POLYMER; POLYVINYL ALCOHOL; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG RETENTION; DRUG SOLUBILITY; DRUG TISSUE LEVEL; GEL PERMEATION CHROMATOGRAPHY; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MOLECULAR WEIGHT; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0030477883     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549609029454     Document Type: Article

References (25)

1. Ashihara, Y., Kono, T., Yamazaki, S., and Inada, Y. (1978) Modification of E. coli L-asparaginase with polyethylene glycol: Disappearance of binding ability to anti-asparaginase serum. Biochem. Biophys. Res. Commun. 83, 385-391.
2. Barrowcliffe, M. P., Zanelli, G. D., Ellison, D., and Jones, J. G. (1990) Clearance of charged and uncharged dextran from normal and injured lungs. J. Appl. Physiol. 68, 341-347.
3. 2-macroglobulin. Anal. Biochem. 131, 25-33.
4. Bendich, A., Abuchowski, A., and Davis, F. F. (1982) Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumor-bearing mice. Clin. Exp. Immunol. 48, 273-278.
5. 125I-labeled human growth hormone of high specific radioactivity. Biochem. J. 89, 114-123.
6. Hashida, M., Atsumi, R., Nishida, K., Nakane, S., Takakura, Y., and Sezaki, H. (1990) Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran. J. Pharmacobiodyn. 13, 441-447.
7. Hershfield, M. S., Buckley, R. H., Greenburg, M. L., Melton, A. L., Schiff, R., Hatem, C., Kurtzberg, J., Marken, M. L., Kobayashi, R. H., Kobayashi, A. L., and Abuchowski, A. N. (1987) Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N. Engl. J. Med. 316, 589-596.
8. Ilium, L., Bright, J., and Davis, S. S. (1989) Targeting of microspheres to sites of inflammation. Int. J. Pharm. 52, 221-224.
9. Kamata, R., Yamamoto, T., Matsumoto, K., and Maeda, H. (1985) A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs. Infect. Immun. 48, 747-753.
10. Kaneo, Y., Tanaka, T., Fujihara, Y., Mon, H., and Iguchi, S. (1988) Delivery of glutathione, as a dextran conjugate, into the liver. Int. J. Pharm. 44, 265-267.
11. Love, W. G., Farr, S. J., Kellaway, I. W., and Williams, B. D. (1990) Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis. Ann. Rheum. Dis. 49, 611-614.
12. Melton, R. G., Wiblin, C. N., Foster, R. L., and Sherwood, R. F. (1987) Covalent linkage of carboxypeptidase G2 to soluble dextran - II. In vivo distribution and fate of conjugate. Biochem. Pharmacol. 36, 105-112.
13. Mizushima, Y. (1985) Lipid microspheres as novel drug carriers. Drugs Exp. Clin. Res. 11, 595-600.
14. Mizushima, Y. (1988) Application of lipid microspheres for targeting therapy. J. Bioact. Comp. Polym. 3,
15. Mizushima, Y., Wada, Y., Etoh, Y., and Watanabe, K. (1983) Anti-inflammatory effects of indomethacin ester incorporated in a lipid microsphere. J. Pharm. Pharmacol. 35, 398-399.
16. Nakajima, N., and Ikada, Y. (1995) Fusogenic activity of various water-soluble polymers. J. Biomater. Sci. Polym. Ed. 6, 751-758.
17. Przybyski, M., Fell, E., and Ringsdorf, H. (1978) Syntheses and characterization of polymeric derivatives of the antitumor agent. Makromol. Chem. 179, 1733-1791.
18. Sunamoto, J., and Iwamoto, K. (1986) Protein-coated and polysaccharide-coated liposomes as drug carriers. CRC Crit. Rev. Ther. Drug Carrier Syst. 2, 117-136.
19. Takakura, Y., Takagi, A., Hashida, M., and Sezaki, H. (1987) Disposition and tumor localization of mitomycin C-dextran conjugates in mice. Pharm. Res. 4, 223-230.
20. Takakura, Y., Atumi, R., Hashida, M., and Sezaki, H. (1990) Disposition characteristics of macromolecules in tumor-bearing mice. Pharm. Res. 7, 339-346.
21. Yamaoka, T., Tabata, Y., and Ikada, Y. (1993) Body distribution profile of polysaccharides after intravenous administration. Drug Deliv. 1, 75-82.
22. Yamaoka, T., Tabata, Y., and Ikada, Y. (1994) Distribution and tissue uptake of polyethylene glycol with different molecular weights after intravenous administration to mice. J. Pharm. Sci. 83, 601-606.
23. Yamaoka, T., Kuroda, M., Tabata, Y., and Ikada, Y. (1995a) Body distribution of dextran derivatives with electric charges after intravenous administration. Int. J. Pharm. 113, 149-157.
24. Yamaoka, T., Tabata, Y., and Ikada, Y. (1995b) Comparison of body distribution of poly(vinyl alchol) with other water-soluble polymers after intravenous administration. J. Pharm. Pharmacol. 47, 470-486.
25. Yoshimoto, T., Nishimura, H., Saito, Y., Sakurai, K., Kamisaki, Y., Wada, H., Sako, M., Tsujino, G., and Inada, Y. (1986) Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia. Jpn. J. Cancer Res. (Gann) 77, 1264-1270.